Related Experiment Video
Updated: May 14, 2026

Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery
Published on: September 30, 2021
Viral therapy for pancreatic cancer: tackle the bad guys with poison
Can Xu1, Haihang Li, Changqing Su
1Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Abstract:
Pancreatic cancer is one of the most devastating diseases with very poor prognosis. Only a small proportion is curable by surgical resection, whilst standard chemotherapy for patients with advanced disease has only modest effect with substantial toxicity. Therefore, there is an urgent need for the development of novel therapeutic approaches to improve the patient outcome. Recently the viral therapy is emerging as a novel effective therapeutic approach for cancer with the potential to selectively treat both primary tumor and metastatic lesions. This review provides an overview of the current status of viral treatment for pancreatic cancer, both in the laboratories and in clinical settings.
Insights
Viral therapy offers a promising new approach for pancreatic cancer, a disease with poor outcomes. This review explores the potential of oncolytic viruses to effectively treat pancreatic tumors and metastases.
Area of Science:
- Oncology
- Virology
- Medical Science
Background:
- Pancreatic cancer has a very poor prognosis and limited treatment options.
- Surgical resection is only curative for a small fraction of patients.
- Standard chemotherapy for advanced pancreatic cancer has modest efficacy and significant toxicity.
Purpose of the Study:
- To review the current status of viral therapy for pancreatic cancer.
- To highlight the potential of oncolytic viruses as a novel therapeutic strategy.
- To discuss applications in both laboratory and clinical settings.
Main Methods:
- Literature review of preclinical and clinical studies on viral therapy for pancreatic cancer.
- Analysis of the mechanisms of action of oncolytic viruses.
- Evaluation of current clinical trial data.
Main Results:
- Viral therapy is an emerging approach with the potential for selective cancer treatment.
- Oncolytic viruses can target both primary pancreatic tumors and metastatic lesions.
- Ongoing research and clinical trials are evaluating the efficacy and safety of viral treatments.
Conclusions:
- Viral therapy represents a promising novel approach for pancreatic cancer.
- Further research and clinical development are crucial to optimize this treatment modality.
- Oncolytic virotherapy holds potential to improve outcomes for pancreatic cancer patients.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmaceutical Poisoning: Treatment Strategies

